Peer-reviewed veterinary case report
Tick-borne infections in pet cats in the US from 2022 to 2025
By Smith, Rachel C et al.·Published in Veterinary parasitology, regional studies and reports·2025·Department of Pathobiology, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Seroprevalence of selected vector-borne agents in pet cats using the SNAP® 4Dx® PLUS, United States, 2022-2025.
- Species:
- cat
Plain-English summary
A study found that 2.6% of pet cats tested in the U.S. showed exposure to at least one tick-borne disease, with the most common being Anaplasma spp. (1.40%). This suggests that while cats are less frequently infected than dogs, they can still be affected by these diseases. The SNAP 4Dx PLUS test was used to check for antibodies and antigens related to these infections. It's important for cat owners to be aware of these potential health risks and discuss testing with their veterinarian, especially if their cat spends time outdoors.
People also search for: cat tick-borne disease symptoms · Anaplasma in cats · cat health check for ticks · how to prevent tick diseases in cats
Abstract
Tick-borne diseases predominate among vector-borne diseases of human and veterinary importance in the United States (US). Many of the most important tick-borne agents in people, including Borrelia burgdorferi, Anaplasma spp., and Ehrlichia spp. are zoonoses capable of infecting domestic pets. These infections can impact animal health with widely varying severity, ranging from subclinical to life-threatening disease. Serological testing is essential for screening and diagnosis of these infections in pets, as well as for epidemiological investigations. While vast amounts of data are available on the seroprevalence of antibodies to B. burgdorferi, Anaplasma spp., and Ehrlichia spp. in domestic dogs, comparatively little data is available in domestic cats. The purpose of this study was to evaluate the prevalence of antibodies to B. burgdorferi, Anaplasma spp., and Ehrlichia spp., as well as antigen of D. immitis, the causative agent of heartworm disease, in a population of apparently healthy pet cats from across the US using the point-of-care (POC) SNAP® 4Dx® PLUS test. This POC test does not visually distinguish between antibodies within the Anaplasma genus and antibodies within the Ehrlichia genus. To address this, additional specific peptide testing was conducted at IDEXX Laboratories for Anaplasma spp. and Ehrlichia spp. seropositive samples. In total, n = 1572 feline serum samples were tested using the SNAP® 4Dx® PLUS. All US states were represented by at least 3 samples, and 2.6 % of cats demonstrated evidence of exposure to ≥1 vector-borne pathogen. Cats in the present study were most commonly exposed to Anaplasma spp. (1.40 %), which contrasts previous seroprevalence reports in cats, in which B. burgdorferi predominates. Seroprevalence of Anaplasma spp. was followed by B. burgdorferi (1.15 %), Ehrlichia spp. (0.38 %), and lastly D. immitis antigen detection (0.13 %). Feline exposure to tick-borne agents observed in the present study was compared with canine seroprevalence reported by the Companion Animal Parasite Council over the same time period. We found that feline exposure was 14-28 % of the exposure prevalence reported in dogs. Although less common than canine infection, continued investigation into feline infection with B. burgdorferi, Anaplasma spp., and Ehrlichia spp. is warranted. Feline susceptibility to these agents, transmission dynamics, pathogenicity, and immunologic response remain poorly described.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41354526/